ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "a08a5b4a-de42-4b34-ae2c-7b2445c821dc"}, "_deposit": {"id": "2012458", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "2012458"}, "status": "published"}, "_oai": {"id": "oai:u-ryukyu.repo.nii.ac.jp:02012458", "sets": ["1642838338003", "1642838407795"]}, "author_link": [], "item_1617186331708": {"attribute_name": "Title", "attribute_value_mlt": [{"subitem_1551255647225": "Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix : a retrospective analysis from a single institution", "subitem_1551255648112": "en"}]}, "item_1617186419668": {"attribute_name": "Creator", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kinjyo, Yoshino", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nagai, Yutaka", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Toita, Takafumi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Kudaka, Wataru", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Ariga, Takuro", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Shimoji, Yuko", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nakasone, Tadaharu", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Taira, Yusuke", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Arakaki, Yoshihisa", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nakamoto, Tomoko", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Wakayama, Akihiko", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Ooyama, Takuma", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Maemoto, Hitoshi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Heianna, Joichi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Aoki, Yoichi", "creatorNameLang": "en"}]}]}, "item_1617186476635": {"attribute_name": "Access Rights", "attribute_value_mlt": [{"subitem_1522299639480": "open access", "subitem_1600958577026": "http://purl.org/coar/access_right/c_abf2"}]}, "item_1617186499011": {"attribute_name": "Rights", "attribute_value_mlt": [{"subitem_1522650717957": "en", "subitem_1522651041219": "Creative Commons Attribution-NonCommercial 4.0"}, {"subitem_1522650717957": "en", "subitem_1522650727486": "https://creativecommons.org/licenses/by-nc/4.0/", "subitem_1522651041219": "https://creativecommons.org/licenses/by-nc/4.0/"}]}, "item_1617186626617": {"attribute_name": "Description", "attribute_value_mlt": [{"subitem_description": "Objective:To compare patients with cervical cancer who were primarily treated with concurrent chemoradiotherapy (CCRT) using 20\u2009mg\u2009m^\u003c-2\u003e CDDP for 5 days every 3 weeks with weekly regimens of 40\u2009mg\u2009m^\u003c-2\u003e. Methods:We retrospectively analyzed 185 patients with Stage IB-IVA squamous-cell carcinoma of the cervix who were treated with CCRT between 2005 and 2013 at our hospital. The CCRT regimen consisted of cisplatin (CDDP) at 20\u2009mg\u2009m^\u003c-2\u003e for 5 days every 3 weeks or 40\u2009mg\u2009m^\u003c-2\u003e weekly, administered concomitantly with RT. Results:The median age was 50 years (range: 22-70 years) in the triweekly group and was 50.5 years (range: 28-70 years) in the weekly group. The 5-year overall survival rate in the triweekly and weekly groups were 82.0% and 83.3%, respectively (p\u2009=\u20090.851); their disease-free survival rate was 79.6% and 78.1%, respectively (p\u2009=\u20090.672). In the triweekly group, 56 patients (50.9%) had grade 3/4 leukopenia, which was significantly higher than that of 11 patients (15%) in the weekly group (p\u2009\u003c\u20090.0001). Conclusion:The weekly CDDP regimen for CCRT seems better in patients with International Federation of Gynecology and Obstetrics Stages IB-IVA squamous-cell carcinoma of the cervix. Advances in knowledge: The weekly CDDP regimen for CCRT seems better in patients with International Federation of Gynecology and Obstetrics Stages IB-IVA squamous-cell carcinoma of the cervix.", "subitem_description_type": "Other"}, {"subitem_description": "\u8ad6\u6587", "subitem_description_type": "Other"}]}, "item_1617186643794": {"attribute_name": "Publisher", "attribute_value_mlt": [{"subitem_1522300295150": "en", "subitem_1522300316516": "The British Institute of Radiology"}]}, "item_1617186702042": {"attribute_name": "Language", "attribute_value_mlt": [{"subitem_1551255818386": "eng"}]}, "item_1617186783814": {"attribute_name": "Identifier", "attribute_value_mlt": [{"subitem_identifier_type": "HDL", "subitem_identifier_uri": "http://hdl.handle.net/20.500.12000/46027"}]}, "item_1617186920753": {"attribute_name": "Source Identifier", "attribute_value_mlt": [{"subitem_1522646500366": "ISSN", "subitem_1522646572813": "0007-1285"}, {"subitem_1522646500366": "ISSN", "subitem_1522646572813": "1748-880X"}]}, "item_1617186941041": {"attribute_name": "Source Title", "attribute_value_mlt": [{"subitem_1522650068558": "en", "subitem_1522650091861": "The British Journal of Radiology"}]}, "item_1617187056579": {"attribute_name": "Bibliographic Information", "attribute_value_mlt": [{"bibliographicIssueNumber": "1076", "bibliographicVolumeNumber": "90"}]}, "item_1617258105262": {"attribute_name": "Resource Type", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_1617265215918": {"attribute_name": "Version Type", "attribute_value_mlt": [{"subitem_1522305645492": "VoR", "subitem_1600292170262": "http://purl.org/coar/version/c_970fb48d4fbd8a85"}]}, "item_1617353299429": {"attribute_name": "Relation", "attribute_value_mlt": [{"subitem_1522306287251": {"subitem_1522306382014": "DOI", "subitem_1522306436033": "https://doi.org/10.1259/bjr.20170241"}}, {"subitem_1522306287251": {"subitem_1522306382014": "DOI", "subitem_1522306436033": "https://doi.org/10.1259/bjr.20170241"}}]}, "item_1617605131499": {"attribute_name": "File", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "download_preview_message": "", "file_order": 0, "filename": "bjr.20170241.pdf", "future_date_message": "", "is_thumbnail": false, "mimetype": "", "size": 0, "url": {"objectType": "fulltext", "url": "https://u-ryukyu.repo.nii.ac.jp/record/2012458/files/bjr.20170241.pdf"}, "version_id": "ee952cd9-fafb-4ca7-81d4-2c02e4f575d8"}]}, "item_title": "Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix : a retrospective analysis from a single institution", "item_type_id": "15", "owner": "1", "path": ["1642838338003", "1642838407795"], "permalink_uri": "http://hdl.handle.net/20.500.12000/46027", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2020-06-04"}, "publish_date": "2020-06-04", "publish_status": "0", "recid": "2012458", "relation": {}, "relation_version_is_last": true, "title": ["Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix : a retrospective analysis from a single institution"], "weko_shared_id": -1}
  1. 学術雑誌論文
  2. その他
  1. 部局別インデックス
  2. 医学部

Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix : a retrospective analysis from a single institution

http://hdl.handle.net/20.500.12000/46027
http://hdl.handle.net/20.500.12000/46027
aed12936-0716-41ab-85d1-ffe7323763e3
名前 / ファイル ライセンス アクション
bjr.20170241.pdf bjr.20170241.pdf
Item type デフォルトアイテムタイプ(フル)(1)
公開日 2020-06-04
タイトル
タイトル Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix : a retrospective analysis from a single institution
言語 en
作成者 Kinjyo, Yoshino

× Kinjyo, Yoshino

en Kinjyo, Yoshino

Nagai, Yutaka

× Nagai, Yutaka

en Nagai, Yutaka

Toita, Takafumi

× Toita, Takafumi

en Toita, Takafumi

Kudaka, Wataru

× Kudaka, Wataru

en Kudaka, Wataru

Ariga, Takuro

× Ariga, Takuro

en Ariga, Takuro

Shimoji, Yuko

× Shimoji, Yuko

en Shimoji, Yuko

Nakasone, Tadaharu

× Nakasone, Tadaharu

en Nakasone, Tadaharu

Taira, Yusuke

× Taira, Yusuke

en Taira, Yusuke

Arakaki, Yoshihisa

× Arakaki, Yoshihisa

en Arakaki, Yoshihisa

Nakamoto, Tomoko

× Nakamoto, Tomoko

en Nakamoto, Tomoko

Wakayama, Akihiko

× Wakayama, Akihiko

en Wakayama, Akihiko

Ooyama, Takuma

× Ooyama, Takuma

en Ooyama, Takuma

Maemoto, Hitoshi

× Maemoto, Hitoshi

en Maemoto, Hitoshi

Heianna, Joichi

× Heianna, Joichi

en Heianna, Joichi

Aoki, Yoichi

× Aoki, Yoichi

en Aoki, Yoichi

アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利情報
言語 en
権利情報 Creative Commons Attribution-NonCommercial 4.0
言語 en
権利情報Resource https://creativecommons.org/licenses/by-nc/4.0/
権利情報 https://creativecommons.org/licenses/by-nc/4.0/
内容記述
内容記述タイプ Other
内容記述 Objective:To compare patients with cervical cancer who were primarily treated with concurrent chemoradiotherapy (CCRT) using 20 mg m^<-2> CDDP for 5 days every 3 weeks with weekly regimens of 40 mg m^<-2>. Methods:We retrospectively analyzed 185 patients with Stage IB-IVA squamous-cell carcinoma of the cervix who were treated with CCRT between 2005 and 2013 at our hospital. The CCRT regimen consisted of cisplatin (CDDP) at 20 mg m^<-2> for 5 days every 3 weeks or 40 mg m^<-2> weekly, administered concomitantly with RT. Results:The median age was 50 years (range: 22-70 years) in the triweekly group and was 50.5 years (range: 28-70 years) in the weekly group. The 5-year overall survival rate in the triweekly and weekly groups were 82.0% and 83.3%, respectively (p = 0.851); their disease-free survival rate was 79.6% and 78.1%, respectively (p = 0.672). In the triweekly group, 56 patients (50.9%) had grade 3/4 leukopenia, which was significantly higher than that of 11 patients (15%) in the weekly group (p < 0.0001). Conclusion:The weekly CDDP regimen for CCRT seems better in patients with International Federation of Gynecology and Obstetrics Stages IB-IVA squamous-cell carcinoma of the cervix. Advances in knowledge: The weekly CDDP regimen for CCRT seems better in patients with International Federation of Gynecology and Obstetrics Stages IB-IVA squamous-cell carcinoma of the cervix.
内容記述タイプ Other
内容記述 論文
出版者
言語 en
出版者 The British Institute of Radiology
言語
言語 eng
資源タイプ
資源タイプ journal article
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
識別子
識別子 http://hdl.handle.net/20.500.12000/46027
識別子タイプ HDL
関連情報
関連識別子
識別子タイプ DOI
関連識別子 https://doi.org/10.1259/bjr.20170241
関連識別子
識別子タイプ DOI
関連識別子 https://doi.org/10.1259/bjr.20170241
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 0007-1285
収録物識別子タイプ ISSN
収録物識別子 1748-880X
収録物名
言語 en
収録物名 The British Journal of Radiology
書誌情報
巻 90, 号 1076
戻る
0
views
See details
Views

Versions

Ver.1 2022-02-02 02:10:11.914811
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON

確認


Powered by WEKO3


Powered by WEKO3